300238
vs
S
Shanghai Composite
300238
Over the past 12 months, Guanhao Biotech Co Ltd has underperformed Shanghai Composite, delivering a return of +22% compared to the Shanghai Composite's +26% growth.
Stocks Performance
300238 vs Shanghai Composite
Performance Gap
300238 vs Shanghai Composite
Performance By Year
300238 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Guanhao Biotech Co Ltd
Glance View
Guanhao Biotech Co. Ltd. engages in the research, development, production, and sale of regenerative medical materials and regenerative medical implant devices. The company is headquartered in Guangzhou, Guangdong and currently employs 557 full-time employees. The company went IPO on 2011-07-06. The firm primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The firm is also engaged in provision of related technological services.
